DENALI THERAPEUTICS INC (DNLI) Institutional Ownership and Insiders Activity

DENALI THERAPEUTICS INC (DNLI) is widely held by institutional investors, with 280 firms reporting positions valued at approximately $4.45B based on SEC Form 13F filings for the quarter ended June 30, 2026.

Banque Cantonale Vaudoise is the largest disclosed holder, reporting approximately $461.00M in DNLI holdings in its latest filing.

Recent insider activity includes 6 tracked Form 4 transactions over the last three months, reflecting ongoing executive and director trading activity.